Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 3, 2015, Pages 342-352

  Bhattacharyya, Sumit ^a,b   Feferman, Leo ^a,b   Tobacman, Joanne K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Arylsulfatase B; BMP; Chondroitin; Sulfatase; Sulfotransferase; Wnt

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CHONDROITIN 4 SULFOTRANSFERASE; GALECTIN 3; N ACETYLGALACTOSAMINE 4 SULFATASE; SMAD3 PROTEIN; SULFOTRANSFERASE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; WNT9A PROTEIN; ARYLSULFATASE B, HUMAN; BMP4 PROTEIN, HUMAN; CHONDROITIN SULFATE; CHST11 PROTEIN, HUMAN; WNT PROTEIN; WNT9A PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BIOSYNTHESIS; CELL MEMBRANE; CHROMATIN IMMUNOPRECIPITATION; COLON MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROMOTER REGION;

MUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL LINE; CHONDROITIN SULFATES; EPITHELIAL CELLS; GALECTIN 3; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; N-ACETYLGALACTOSAMINE-4-SULFATASE; PROMOTER REGIONS, GENETIC; SULFOTRANSFERASES; WNT PROTEINS;

EID: 84923003244     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.12.009     Document Type: Article

References (39)

1. Yang A., Bhattacharyya S., Linhardt R.J., Tobacman J.K. Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells. Biochimie 2012, 94(6):1309-1316.
2. Bhattacharyya S., Feferman L., Tobacman J.K. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3. J. Biol. Chem. 2014, 289(25):17564-17575.
3. Bhattacharyya S., Feferman L., Borthakur S., Tobacman J.K. Common food additive carrageenan stimulates Wnt/β-catenin signaling in colonic epithelium by inhibition of nucleoredoxin reduction. Nutr. Cancer 2014, 66(1):117-127.
4. Bhattacharyya S., Borthakur A., Dudeja P.K., Tobacman J.K. Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates Wnt/β-catenin pathway in normal human colonic epithelial cells. Dig. Dis. Sci. 2007, 52(10):2766-2774.
5. Hintze V., Moeller S., Schnabelrauch M., Bierbaum S., Viola M., Worch H., Schamweber D. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4). Biomacromolecules 2009, 10(91):3290-3297.
6. Viviano B.L., Paine-Saunders S., Gasiunas N., Gallagher J., Saunders S. Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of morphogenetic protein antagonist Noggin. J. Biol. Chem. 2004, 279(7):5604-5611.
7. Salbach-Hirsch J., Ziegler N., Thiele S., Moeller S., Schnabelrauch M., Hintze V., Schweber D., Rauner M., Hofbauer L.C. Sulfated glycosaminoglycans support osteoblast functions and concurrently suppress osteoclasts. J. Cell. Biochem. 2014, 115(6):1101-1111.
8. Miyazaki T., Miyauchi S., Tawada A., Anada T., Matsuzaka S., Suzuki O. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J. Cell. Physiol. 2008, 217(3):769-777.
9. Reichsman F., Smith L., Cumberledge S. Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J. Cell Biol. 1996, 135(3):819-827.
10. Nadanaka S., Ishida M., Ikegami M., Kitagawa H. Chondroitin 4-O-sulfotransferase-1 modulates Wnt-3a signaling through control of E disaccharide expression of chondroitin sulfate. J. Biol. Chem. 2008, 283(40):27333-27343.
11. Nadanaka S., Kinouchi H., Taniguchi-Morita K., Tamura J., Kitagawa H. Down-regulation of chondroitin-4-O-sulfotransfearase-1 by Wnt signaling triggers diffusion of Wnt-3a. J. Biol. Chem. 2011, 286(6):4199-4208.
12. Shortkroff S., Yates K.E. Alteration of matrix glycosaminoglycans diminishes articular chondrocytes' response to a canonical Wnt signal. Osteoarthr. Cartil. 2007, 15(2):147-154.
13. Rosen S.D., Lemjabbar-Alaoui H. SULF-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin. Ther. Targets 2010, 14(9):935-949.
14. Ai X., Do A.T., Lozynska O., Kusche-Gullberg M., Lindahl U., Emerson C.P. QSULF1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J. Cell Biol. 2003, 162:341-351.
15. Bhattacharyya S., Tobacman J.K. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. PLoS One 2012, 7(3):e33250.
16. Bhattacharyya S., Feferman L., Tobacman J.K. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects. Oncogene 2013, 33(47):5467-5476.
17. Moyer M.P., Manzano L.A., Merriman R.L., Stauffer J.S., Tanzer L.R. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell. Dev. Biol. Anim. 1996, 32:315-317.
18. http://craniofacial.jax.org/publications/curtainetalnm3775m1J/html.
19. Borthakur A., Bhattacharyya S., Dudeja P.K., Tobacman J.K. Carrageenan-induced Interleukin-8 production through BCL10 pathway in normal human colonic epithelial cells. AJP: Gastrointest. Liver Physiol. 2007, 292:G829-G838.
20. http://primer3.wi.mit.edu.
21. Klüppel M., Vallis K.A., Wrana J.L. A high-throughput induction gene trap approach defines C4ST as a target of BMP signals. Mech. Dev. 2002, 118:77-89.
22. Prokova V., Mavridou S., Papakosta P., Kardassis D. Characterization of a novel transcriptionally active domain in the transforming growth factor beta-regulated Smad3 protein. Nucleic Acids Res. 2005, 33(12):2708-2721.
23. Upton P.D., Davies R.J., Tajsic T., Morrell N.W. Transforming Growth Factor-B1 represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle. Am. J. Respir. Cell Mol. Biol. 2013, 49(6):1135-1146.
24. Wang G., Long J., Matsuura I., He D., Liu F. The Smad3 linker region contains a transcriptional activation domain. Biochem. J. 2005, 386:29-34.
25. Inman G.J. Commentary: linking Smads and transcriptional activation. Biochem. J. 2005, 386:e1-e3.
26. Bhattacharyya S., Solakyildirim K., Zhang Z., Linhardt R.J., Tobacman J.K. Cell-bound IL-8 increases in bronchial epithelial cells following Arylsulfatase B silencing. Am. J. Respir. Cell Mol. Biol. 2010, 42(1):51-61.
27. Soshnikova N., Zechner D., Huelsken J., Mishina Y., Behringer R.R., Taketo M.M., Crenshaw E.B., Birchmeier W. Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb. Genes Dev. 2003, 17(16):1963-1966.
28. Jin E.J., Erickson C.A., Takada S., Burrus L.W. Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo. Dev. Biol. 2001, 233(1):22-37.
29. Hashiguchi M., Mullins M.C. Anteroposterior and dorsoventral patterning are coordinated by an identical patterning clock. Development 2013, 140(9):1970-1980.
30. Kotlo K., Bhattacharyya S., Yang B., Feferman L., Tejaskumar S., Linhardt R., Danziger R., Tobacman J.K. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin. Glycoconj. J. 2013, 30(7):667-676.
31. Baker J.C., Beddington R.S., Harland R.M. Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development. Genes Dev. 1999, 13(23):3149-3159.
32. Kuroda K., Kuang S., Taketo M.M., Rudnicki M.A. Canonical Wnt signaling induces BMP-4 to specify slow myofibrogenesis of fetal myoblasts. PLoS Genet. 2012, 8(11):e1003031.
33. Shu W., Guttentag S., Wang Z., Andi T., Ballard P., Lu M.M., Piccolo S., Birchmeier W., Whitsett J.A., Millar S.E., Morrisey E.E. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal distal patterning in the lung. Dev. Biol. 2005, 283(1):226-239.
34. Zhang R., Oyajobi B.O., Harris S.E., Chen D., Tsao C., Deng H.W., Zhao M. Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 2013, 52(1):145-156.
35. Ohtake S., Kimata K., Habuchi O. A unique nonreducing terminal modification of chondroitin sulfate by N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase. J. Biol. Chem. 2003, 278(40):38443-38452.
36. Ohtake S., Kondo S., Morisaki T., Matsumura K., Kimata K., Habuchi O. Expression of sulfotransferases involved in the biosynthesis of chondroitin sulfate E in the bone marrow derived mast cells. BBA 2008, 1780:687-695.
37. Dani N., Nahm M., Lee S., Broadie K. A targeted glycan-related gene screen reveals heparan sulfate proteoglycan sulfation regulates WNT and BMP trans-synaptic signaling. Bone 2013, 52(1):145-156.
38. Doubravska L., Krausova M., Gradl D., Vojtechova M., Tumova L., Lukas J., Valenta T., Pospichalova V., Fafilek B., Plachy J., Sebesta O., Korinek V. Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for lipidation at cysteine and is essential for Wnt signalling. Cell. Signal. 2011, 23(5):837-848.
39. Cruciat C.-M., Niehrs C. Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol. 2013, 5:a015081.